Donald Castell to Histamine H2 Antagonists
This is a "connection" page, showing publications Donald Castell has written about Histamine H2 Antagonists.
Connection Strength
2.712
-
Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
Score: 0.486
-
Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
Score: 0.291
-
Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
Score: 0.255
-
Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005; 18(6):370-3.
Score: 0.228
-
Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
Score: 0.218
-
Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther. 2002 Mar; 16(3):473-7.
Score: 0.188
-
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001 Sep; 15(9):1351-6.
Score: 0.181
-
A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
Score: 0.160
-
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. Am J Gastroenterol. 1997 Mar; 92(3):429-37.
Score: 0.133
-
Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1991; 5 Suppl 1:59-67.
Score: 0.087
-
Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6.
Score: 0.072
-
Gastroesophageal reflux disease: natural history and long-term medical and surgical outcomes. Clin Cornerstone. 2003; 5(4):51-7; discussion 58-60.
Score: 0.050
-
Medical therapy for gastroesophageal reflux disease. Mayo Clin Proc. 2001 Jan; 76(1):102-6.
Score: 0.043
-
Medical therapy of supraesophageal gastroesophageal reflux disease. Am J Med. 2000 Mar 06; 108 Suppl 4a:170S-177S.
Score: 0.041
-
Barrett's esophagus: continuing questions and controversy. Gastrointest Endosc. 1999 Mar; 49(3 Pt 2):S5-8.
Score: 0.038
-
Approach to the patient with unexplained chest pain. Compr Ther. 1997 Apr; 23(4):249-53.
Score: 0.033
-
Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD). Semin Thorac Cardiovasc Surg. 1997 Apr; 9(2):169-72.
Score: 0.033
-
Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996 Sep; 91(9):1715-8.
Score: 0.032
-
Gastroesophageal reflux disease. Current strategies for patient management. Arch Fam Med. 1996 Apr; 5(4):221-7.
Score: 0.031
-
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases. Am J Gastroenterol. 1995 Oct; 90(10):1874-7.
Score: 0.030
-
Long-term management of GERD: the pill, the knife, or the endoscope? Gastrointest Endosc. 1994 Mar-Apr; 40(2 Pt 1):252-3.
Score: 0.027
-
Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med. 1991 Mar; 151(3):448-54.
Score: 0.022
-
Respiratory complications of gastroesophageal reflux. Am Fam Physician. 1988 Feb; 37(2):169-72.
Score: 0.018
-
Future medical therapy of reflux esophagitis. J Clin Gastroenterol. 1986; 8 Suppl 1:81-5.
Score: 0.015